Correlation Between Champions Oncology and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both Champions Oncology and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Champions Oncology and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Champions Oncology and CytomX Therapeutics, you can compare the effects of market volatilities on Champions Oncology and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Champions Oncology with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Champions Oncology and CytomX Therapeutics.
Diversification Opportunities for Champions Oncology and CytomX Therapeutics
0.28 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Champions and CytomX is 0.28. Overlapping area represents the amount of risk that can be diversified away by holding Champions Oncology and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and Champions Oncology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Champions Oncology are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of Champions Oncology i.e., Champions Oncology and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between Champions Oncology and CytomX Therapeutics
Given the investment horizon of 90 days Champions Oncology is expected to generate 0.85 times more return on investment than CytomX Therapeutics. However, Champions Oncology is 1.18 times less risky than CytomX Therapeutics. It trades about 0.12 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about 0.03 per unit of risk. If you would invest 398.00 in Champions Oncology on August 29, 2024 and sell it today you would earn a total of 35.00 from holding Champions Oncology or generate 8.79% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Champions Oncology vs. CytomX Therapeutics
Performance |
| Timeline |
| Champions Oncology |
| CytomX Therapeutics |
Champions Oncology and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Champions Oncology and CytomX Therapeutics
The main advantage of trading using opposite Champions Oncology and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Champions Oncology position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.| Champions Oncology vs. Fonar | Champions Oncology vs. Burning Rock Biotech | Champions Oncology vs. Sera Prognostics | Champions Oncology vs. Exagen Inc |
| CytomX Therapeutics vs. Eliem Therapeutics | CytomX Therapeutics vs. Scpharmaceuticals | CytomX Therapeutics vs. Milestone Pharmaceuticals | CytomX Therapeutics vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Other Complementary Tools
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| CEOs Directory Screen CEOs from public companies around the world |